Discussions of Life Expectancy and Changes in Illness Understanding in Patients With Advanced Cancer

por Epstein, Andrew S., Prigerson, Holly G., O’Reilly, Eileen M., Maciejewski, Paul K.
Publicado 2016

Duration of therapy for locally advanced pancreatic cancer: Does it matter?

por Tuli, Richard, David, John, Lobaugh, Stephanie, Zhang, Zhigang, O'Reilly, Eileen M.
Publicado 2020

Does acute pancreatitis herald pancreatic ductal adenocarcinoma? A multicenter electronic health research network study

por Singh, Ritu R., Klein, Alison P., Sharma, Neil R., O'Reilly, Eileen M.
Publicado 2022

Pancreatic Cancer: BRCA Targeted Therapy and Beyond

por Keane, Fergus, O’Connor, Catherine A., Park, Wungki, Seufferlein, Thomas, O’Reilly, Eileen M.
Publicado 2023

Pancreatic adenocarcinoma: insights into patterns of recurrence and disease behavior

por Sahin, Ibrahim H., Elias, Harold, Chou, Joanne F., Capanu, Marinela, O’Reilly, Eileen M.
Publicado 2018

Prior irinotecan exposure does not preclude benefit to liposomal irinotecan in patients with metastatic pancreatic ductal adenocarcinoma

por Yu, Kenneth H., Cockrum, Paul, Surinach, Andy, Lamarre, Neil, Wang, Shu, O'Reilly, Eileen M.
Publicado 2023

Neoadjuvant Treatment in Patients With Resectable and Borderline Resectable Pancreatic Cancer

por Janssen, Quisette P., O'Reilly, Eileen M., van Eijck, Casper H. J., Groot Koerkamp, Bas
Publicado 2020

Reducing nihilism in metastatic pancreatic ductal adenocarcinoma: Treatment, sequencing, and effects on survival outcomes

por O'Reilly, Eileen M., Cockrum, Paul, Surinach, Andy, Wu, Zheng, Dillon, Allison, Yu, Kenneth H.
Publicado 2020

Dramatic, durable response to therapy in gBRCA2-mutated pancreas neuroendocrine carcinoma: opportunity and challenge

por Keane, Fergus, Bajwa, Raazi, Selenica, Pier, Park, Wungki, Roehrl, Michael H., Reis-Filho, Jorge S., Mandelker, Diana, O’Reilly, Eileen M.
Publicado 2023

Neoadjuvant treatment of pancreatic adenocarcinoma: a systematic review and meta-analysis of 5520 patients

por Dhir, Mashaal, Malhotra, Gautam K., Sohal, Davendra P.S., Hein, Nicholas A., Smith, Lynette M., O’Reilly, Eileen M., Bahary, Nathan, Are, Chandrakanth
Publicado 2017

Pancreatic cancer stem cells may define tumor stroma characteristics and recurrence patterns in pancreatic ductal adenocarcinoma

por Askan, Gokce, Sahin, Ibrahim Halil., Chou, Joanne F., Yavas, Aslihan, Capanu, Marinela, Iacobuzio-Donahue, Christine A., Basturk, Olca, O’Reilly, Eileen M.
Publicado 2021

Acquired resistance to immunotherapy in MMR-D pancreatic cancer

por Hu, Zishuo Ian, Hellmann, Matthew D., Wolchok, Jedd D., Vyas, Monika, Shia, Jinru, Stadler, Zsofia K., Diaz, Luis A., O’Reilly, Eileen M.
Publicado 2018

Circulating Tumor and Invasive Cell Gene Expression Profile Predicts Treatment Response and Survival in Pancreatic Adenocarcinoma

por Yu, Kenneth H., Ricigliano, Mark, McCarthy, Brian, Chou, Joanne F., Capanu, Marinela, Cooper, Brandon, Bartlett, Andrew, Covington, Christina, Lowery, Maeve A., O’Reilly, Eileen M.
Publicado 2018

Postoperative outcomes following pancreaticoduodenectomy: how should age affect clinical practice?

por Faraj, Walid, Alameddine, Raafat, Mukherji, Deborah, Musallam, Khaled, Haydar, Ali, ELoubiedi, Mohamed, Shamseddine, Ali, Halal, Ali, Abou-Alfa, Ghassan K, O’Reilly, Eileen M, Jamali, Faek, Khalife, Mohamed
Publicado 2013

Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of Necuparanib Combined with Nab‐Paclitaxel and Gemcitabine in Patients with Metastatic Pancreatic Cancer: Phase...

por O'Reilly, Eileen M., Roach, James, Miller, Paul, Yu, Kenneth H., Tjan, Catherine, Rosano, Molly, Krause, Silva, Avery, William, Wolf, Julie, Flaherty, Keith, Nix, Darrell, Ryan, David P.
Publicado 2017

Pancreatic cancer: Cutaneous metastases, clinical descriptors and outcomes

por Gu, Lilly, Mehta, Paras P., Rao, Devika, Rotemberg, Veronica, Capanu, Marinela, Chou, Joanne, Lin, Sabrina, Sigel, Carlie S., Busam, Klaus J., Boyce, Lindsay, Gordon, Allison, O'Reilly, Eileen M.
Publicado 2022

Metastatic well differentiated serotonin-producing pancreatic neuroendocrine tumor with carcinoid heart disease: a case report

por Kudelka, Matthew R., Abou-Alfa, Ghassan K., O’Reilly, Eileen M., Foote, Michael B., Sirohi, Bhawna, Elias, Rawad, Shamseddine, Ali, Paroder, Viktoriya, Moussa, Amgad M., Cohen, Paul, Ganesh, Karuna
Publicado 2023

Overall survival and clinical characteristics of BRCA mutation carriers with stage I/II pancreatic cancer

por Golan, Talia, Sella, Tal, O'Reilly, Eileen M, Katz, Matthew H G, Epelbaum, Ron, Kelsen, David P, Borgida, Ayelet, Maynard, Hannah, Kindler, Hedy, Friedmen, Eitan, Javle, Milind, Gallinger, Steven
Publicado 2017

Preliminary study of tumor heterogeneity in imaging predicts two year survival in pancreatic cancer patients

por Chakraborty, Jayasree, Langdon-Embry, Liana, Cunanan, Kristen M., Escalon, Joanna G., Allen, Peter J., Lowery, Maeve A., O’Reilly, Eileen M., Gönen, Mithat, Do, Richard G., Simpson, Amber L.
Publicado 2017

Rivaroxaban thromboprophylaxis in ambulatory patients with pancreatic cancer: Results from a pre‐specified subgroup analysis of the randomized CASSINI study

por Vadhan‐Raj, Saroj, McNamara, Mairéad G., Venerito, Marino, Riess, Hanno, O'Reilly, Eileen M., Overman, Michael J., Zhou, Xiao, Vijapurkar, Ujjwala, Kaul, Simrati, Wildgoose, Peter, Khorana, Alok A.
Publicado 2020